Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraportal Tacrolimus During Liver Transplantation to Reduce Ischemia-Reperfusion Injury
2007-006049-41Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in decompensated cirrhosis and Liver graft ischemia-reperfusion injury (LIRI) comparing Intraportal Tacrolimus with Intraportal saline placebo (2 arms). Primary endpoint: Initial liver function based on liver function parameters and coagulation factors. Started Jan 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
decompensated cirrhosisLiver graft ischemia-reperfusion injury (LIRI)
Beyond the preview
Go deeper on 2007-006049-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006049-41.